| 摘要 |
<p>The present invention encompasses type-1 IFN and IFNE-induced PD marker expression profiles, kits, and methods for identifying such IFNE-induced PD marker expression profiles. The type-I IFN and IFNE-induced PD marker expression profiles may also be used in, for example, methods of treating patients having a type-I IFN or IFNE-mediated disorder, methods of monitoring disease progression of patients receiving treatment with a therapeutic agent that binds to and modulates IFNE activity, identifying patients as candidates to receive a therapeutic that binds to and neutralizes IFNE activity, and in diagnosing or providing a prognosis to patients having IFNE-induced disorders. ® KIPO & WIPO 2009</p> |
